These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 395067

  • 1. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE, Buysschaert M, Lambotte L.
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract] [Full Text] [Related]

  • 2. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E, Moulin JP, Tavares S, Bourelly N, Lassmann V, Vague P.
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract] [Full Text] [Related]

  • 3. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A, Schultz M, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [Abstract] [Full Text] [Related]

  • 4. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J, Wolf E, Cordes U, Hassingen W.
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [Abstract] [Full Text] [Related]

  • 5. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.
    Brunetti P, Massi-Benedetti M, Puxeddu A, Santeusanio F, Calabrese G, Bolli G, Scionti L, Angeletti G.
    Horm Metab Res Suppl; 1979; (8):81-6. PubMed ID: 395095
    [Abstract] [Full Text] [Related]

  • 6. Use of an artificial beta cell in surgery.
    Horwitz DL, Schwartz SS.
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [Abstract] [Full Text] [Related]

  • 7. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD, Braun G, Naegele R, Bresch M, Lehmann U.
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [Abstract] [Full Text] [Related]

  • 8. Development of a closed-loop artificial pancreas.
    Kraegen EW, Whiteside R, Bell D, Chia YO, Lazarus L.
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [Abstract] [Full Text] [Related]

  • 9. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J, Selam JL, Pham TC, Orsetti A.
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [Abstract] [Full Text] [Related]

  • 10. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [Abstract] [Full Text] [Related]

  • 11. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
    Kerner W, Beischer W, Herfarth C, Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
    [Abstract] [Full Text] [Related]

  • 12. Control algorithms for artificial beta cell.
    Clemens AH.
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [Abstract] [Full Text] [Related]

  • 13. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER, Blatter G, Morell B.
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [Abstract] [Full Text] [Related]

  • 14. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W, Beischer W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [Abstract] [Full Text] [Related]

  • 15. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC, Viberti GC, Keen H, Parsons JA, Alberti KG.
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [Abstract] [Full Text] [Related]

  • 16. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K, Kritz H, Kaspar L, Brändle J, Franetzki M.
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [Abstract] [Full Text] [Related]

  • 17. Insulin treatment during diabetic coma with an artificial endocrine pancreas.
    Pfeiffer EF, Kerner W, Beischer W, Klier M.
    Horm Metab Res Suppl; 1979; (8):150-5. PubMed ID: 43829
    [No Abstract] [Full Text] [Related]

  • 18. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K, Christiansen JS, Svendsen PA, Bojsen J.
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [Abstract] [Full Text] [Related]

  • 19. [Artificial endocrine pancreas (author's transl)].
    Kruse-Jarres JD.
    J Clin Chem Clin Biochem; 1979 Jul; 17(7):457-63. PubMed ID: 383880
    [Abstract] [Full Text] [Related]

  • 20. Therapeutical application of artificial beta-cell in surgery and obstetrics.
    Brunetti P, Puxeddu A, Calabrese G, Massi-Benedetti M, Santeusanio F, Bolli G, Scionti L, Bueti A, Angeletti G.
    Horm Metab Res Suppl; 1979 Jul; (8):162-5. PubMed ID: 395074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.